| Assay ID | Title | Year | Journal | Article |
|---|
| AID1346986 | P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
| AID1296008 | Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening | 2020 | SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
| Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening. |
| AID1346987 | P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
| AID1347102 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347103 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347424 | RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1) | 2019 | The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
| Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens. |
| AID1347108 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347086 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID1347098 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347107 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347407 | qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection | 2020 | ACS chemical biology, 07-17, Volume: 15, Issue:7
| High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle. |
| AID1347083 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID1347082 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID1347097 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347089 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347105 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347096 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347099 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347091 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347092 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347154 | Primary screen GU AMC qHTS for Zika virus inhibitors | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
| AID1347095 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347104 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347090 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347101 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1508630 | Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay | 2021 | Cell reports, 04-27, Volume: 35, Issue:4
| A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. |
| AID1347094 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347425 | Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1) | 2019 | The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
| Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens. |
| AID1347093 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347100 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347106 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID504749 | qHTS profiling for inhibitors of Plasmodium falciparum proliferation | 2011 | Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
| Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets. |
| AID1172741 | Antibacterial activity against Pseudomonas aeruginosa CCM 1961 after 72 hrs by microdilution broth method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172746 | Fungicidal activity against Candida albicans ATCC 44859 after 48 hrs by modified standard CSLI M27-A2 method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172762 | Antifungal activity against Absidia corymbifera 272 after 24 hrs by modified standard CSLI M27-A2 method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172757 | Antifungal activity against Trichosporon asahii 1188 after 48 hrs by modified standard CSLI M27-A2 method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172721 | Antibacterial activity against Staphylococcus aureus CCM 4516/08 after 48 hrs by microdilution broth method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172731 | Bactericidal activity against Enterococcus sp. J 14365/08 after 48 hrs by microdilution broth method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172736 | Antibacterial activity against Klebsiella pneumoniae D 11750/08 after 48 hrs by microdilution broth method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID158688 | Inhibitory activity against Plasmodium falciparum | 1997 | Journal of medicinal chemistry, Oct-24, Volume: 40, Issue:22
| Antimalarial activity of molecules interfering with Plasmodium falciparum phospholipid metabolism. Structure-activity relationship analysis. |
| AID1172764 | Fungicidal activity against Absidia corymbifera 272 after 48 hrs by modified standard CSLI M27-A2 method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172750 | Antifungal activity against Candida krusei E28 after 24 hrs by modified standard CSLI M27-A2 method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID551747 | Antibacterial activity against Klebsiella pneumoniae ATCC 13883 after 12 to 18 hrs by twofold dilution method | 2011 | Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
| Synthesis and antibacterial activity study of a novel class of cationic anthraquinone analogs. |
| AID1172745 | Antifungal activity against Candida albicans ATCC 44859 after 48 hrs by modified standard CSLI M27-A2 method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172724 | Antibacterial activity against Staphylococcus aureus H 5996/08 after 48 hrs by microdilution broth method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172730 | Antibacterial activity against Enterococcus sp. J 14365/08 after 48 hrs by microdilution broth method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172763 | Antifungal activity against Absidia corymbifera 272 after 48 hrs by modified standard CSLI M27-A2 method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172752 | Fungicidal activity against Candida krusei E28 after 48 hrs by modified standard CSLI M27-A2 method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID763597 | Cytotoxicity against human HeLa cells after 72 hrs by MTT assay | 2013 | European journal of medicinal chemistry, Aug, Volume: 66 | Synthesis, self-aggregation and biological properties of alkylphosphocholine and alkylphosphohomocholine derivatives of cetyltrimethylammonium bromide, cetylpyridinium bromide, benzalkonium bromide (C16) and benzethonium chloride. |
| AID244727 | Minimum bactericidal concentration against Shigella sonnei | 2005 | Journal of medicinal chemistry, Jun-02, Volume: 48, Issue:11
| Synthesis and antibacterial properties of novel hydrolyzable cationic amphiphiles. Incorporation of multiple head groups leads to impressive antibacterial activity. |
| AID1172738 | Antibacterial activity against Klebsiella pneumoniae J 14368/08 after 24 hrs by microdilution broth method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172748 | Antifungal activity against Candida tropicalis 156 after 48 hrs by modified standard CSLI M27-A2 method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172732 | Antibacterial activity against Escherichia coli CCM 4517 after 24 hrs by microdilution broth method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172742 | Antibacterial activity against Pseudomonas aeruginosa CCM 1961 after 120 hrs by microdilution broth method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172740 | Bactericidal activity against Klebsiella pneumoniae J 14368/08 after 48 hrs by microdilution broth method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID244729 | Minimum bactericidal concentration against Enterococcus faecalis | 2005 | Journal of medicinal chemistry, Jun-02, Volume: 48, Issue:11
| Synthesis and antibacterial properties of novel hydrolyzable cationic amphiphiles. Incorporation of multiple head groups leads to impressive antibacterial activity. |
| AID1131158 | Antibacterial activity against Pseudomonas aeruginosa MB418 at 200 ug/mL | 1979 | Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
| Antibacterial N-[omega, omega'-bis(alicyclic and aryl)-sec-alkyl]poly(methylene)triamine and -tetramine hydrochloride salts. |
| AID1172725 | Bactericidal activity against Staphylococcus aureus H 5996/08 after 48 hrs by microdilution broth method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID551750 | Antibacterial activity against Enterococcus faecalis ATCC 29212 after 12 to 18 hrs by twofold dilution method | 2011 | Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
| Synthesis and antibacterial activity study of a novel class of cationic anthraquinone analogs. |
| AID1172737 | Bactericidal activity against Klebsiella pneumoniae D 11750/08 after 24 hrs by microdilution broth method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID763586 | Amoebicidal activity against Acanthamoeba quina clinical isolate AcaVNAK03 assessed as minimum trophocidal concentration after 48 hrs by trypan blue exclusion assay | 2013 | European journal of medicinal chemistry, Aug, Volume: 66 | Synthesis, self-aggregation and biological properties of alkylphosphocholine and alkylphosphohomocholine derivatives of cetyltrimethylammonium bromide, cetylpyridinium bromide, benzalkonium bromide (C16) and benzethonium chloride. |
| AID1172734 | Bactericidal activity against Escherichia coli CCM 4517 after 48 hrs by microdilution broth method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID551746 | Antibacterial activity against Staphylococcus aureus ATCC 25923 after 12 to 18 hrs by twofold dilution method | 2011 | Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
| Synthesis and antibacterial activity study of a novel class of cationic anthraquinone analogs. |
| AID632873 | Inhibition of Bacillus subtilis RNA polymerase using [alpha-32P]-UTP at 0.2 mM pretreated for 5 mins measured after 15 mins by electrophoresis analysis | 2011 | Journal of medicinal chemistry, Nov-24, Volume: 54, Issue:22
| Lipophosphonoxins: new modular molecular structures with significant antibacterial properties. |
| AID1172749 | Fungicidal activity against Candida tropicalis 156 after 48 hrs by modified standard CSLI M27-A2 method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172747 | Antifungal activity against Candida tropicalis 156 after 24 hrs by modified standard CSLI M27-A2 method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1131157 | Antibacterial activity against Pseudomonas aeruginosa MB2245 at 200 ug/mL | 1979 | Journal of medicinal chemistry, Nov, Volume: 22, Issue:11
| Antibacterial N-[omega, omega'-bis(alicyclic and aryl)-sec-alkyl]poly(methylene)triamine and -tetramine hydrochloride salts. |
| AID1172722 | Bactericidal activity against Staphylococcus aureus CCM 4516/08 after 48 hrs by microdilution broth method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID551749 | Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 12 to 18 hrs by twofold dilution method | 2011 | Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
| Synthesis and antibacterial activity study of a novel class of cationic anthraquinone analogs. |
| AID763588 | Antimycotic activity against Candida albicans ATCC 60193 after 48 hrs by NCCLS M-27 microdilution assay | 2013 | European journal of medicinal chemistry, Aug, Volume: 66 | Synthesis, self-aggregation and biological properties of alkylphosphocholine and alkylphosphohomocholine derivatives of cetyltrimethylammonium bromide, cetylpyridinium bromide, benzalkonium bromide (C16) and benzethonium chloride. |
| AID244728 | Minimum bactericidal concentration against Escherichia coli | 2005 | Journal of medicinal chemistry, Jun-02, Volume: 48, Issue:11
| Synthesis and antibacterial properties of novel hydrolyzable cationic amphiphiles. Incorporation of multiple head groups leads to impressive antibacterial activity. |
| AID1172755 | Fungicidal activity against Candida glabrata 20/I after 48 hrs by modified standard CSLI M27-A2 method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172768 | Cytotoxicity against CHOK1 cells after 24 hrs by MTT assay | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID551744 | Antibacterial activity against Mycobacterium smegmatis ATCC 14468 after 12 to 18 hrs by twofold dilution method | 2011 | Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
| Synthesis and antibacterial activity study of a novel class of cationic anthraquinone analogs. |
| AID1172739 | Antibacterial activity against Klebsiella pneumoniae J 14368/08 after 48 hrs by microdilution broth method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172727 | Antibacterial activity against Staphylococcus epidermidis H 6966/08 after 48 hrs by microdilution broth method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID551748 | Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 after 12 to 18 hrs by twofold dilution method | 2011 | Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
| Synthesis and antibacterial activity study of a novel class of cationic anthraquinone analogs. |
| AID1172744 | Antifungal activity against Candida albicans ATCC 44859 after 24 hrs by modified standard CSLI M27-A2 method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172733 | Antibacterial activity against Escherichia coli CCM 4517 after 48 hrs by microdilution broth method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID763592 | Cytotoxicity against HUVEC after 72 hrs by MTT assay | 2013 | European journal of medicinal chemistry, Aug, Volume: 66 | Synthesis, self-aggregation and biological properties of alkylphosphocholine and alkylphosphohomocholine derivatives of cetyltrimethylammonium bromide, cetylpyridinium bromide, benzalkonium bromide (C16) and benzethonium chloride. |
| AID763596 | Cytotoxicity against human CCRF-CEM cells after 72 hrs by MTT assay | 2013 | European journal of medicinal chemistry, Aug, Volume: 66 | Synthesis, self-aggregation and biological properties of alkylphosphocholine and alkylphosphohomocholine derivatives of cetyltrimethylammonium bromide, cetylpyridinium bromide, benzalkonium bromide (C16) and benzethonium chloride. |
| AID1172751 | Antifungal activity against Candida krusei E28 after 48 hrs by modified standard CSLI M27-A2 method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172760 | Antifungal activity against Aspergillus fumigatus 231 after 48 hrs by modified standard CSLI M27-A2 method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID496819 | Antimicrobial activity against Plasmodium falciparum | 2010 | Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
| Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. |
| AID551751 | Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 51299 after 12 to 18 hrs by twofold dilution method | 2011 | Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
| Synthesis and antibacterial activity study of a novel class of cationic anthraquinone analogs. |
| AID763594 | Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay | 2013 | European journal of medicinal chemistry, Aug, Volume: 66 | Synthesis, self-aggregation and biological properties of alkylphosphocholine and alkylphosphohomocholine derivatives of cetyltrimethylammonium bromide, cetylpyridinium bromide, benzalkonium bromide (C16) and benzethonium chloride. |
| AID551745 | Antibacterial activity against Escherichia coli ATCC 25922 after 12 to 18 hrs by twofold dilution method | 2011 | Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
| Synthesis and antibacterial activity study of a novel class of cationic anthraquinone analogs. |
| AID1172723 | Antibacterial activity against Staphylococcus aureus H 5996/08 after 24 hrs by microdilution broth method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID763593 | Cytotoxicity against human MDA-MB-231 cells after 72 hrs by MTT assay | 2013 | European journal of medicinal chemistry, Aug, Volume: 66 | Synthesis, self-aggregation and biological properties of alkylphosphocholine and alkylphosphohomocholine derivatives of cetyltrimethylammonium bromide, cetylpyridinium bromide, benzalkonium bromide (C16) and benzethonium chloride. |
| AID1172766 | Antifungal activity against Trichophyton mentagrophytes 445 after 120 hrs by modified standard CSLI M27-A2 method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172756 | Antifungal activity against Trichosporon asahii 1188 after 24 hrs by modified standard CSLI M27-A2 method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172754 | Antifungal activity against Candida glabrata 20/I after 48 hrs by modified standard CSLI M27-A2 method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172759 | Antifungal activity against Aspergillus fumigatus 231 after 24 hrs by modified standard CSLI M27-A2 method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172765 | Antifungal activity against Trichophyton mentagrophytes 445 after 72 hrs by modified standard CSLI M27-A2 method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172726 | Antibacterial activity against Staphylococcus epidermidis H 6966/08 after 24 hrs by microdilution broth method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172753 | Antifungal activity against Candida glabrata 20/I after 24 hrs by modified standard CSLI M27-A2 method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID244730 | Minimum bactericidal concentration against Staphylococcus aureus | 2005 | Journal of medicinal chemistry, Jun-02, Volume: 48, Issue:11
| Synthesis and antibacterial properties of novel hydrolyzable cationic amphiphiles. Incorporation of multiple head groups leads to impressive antibacterial activity. |
| AID763595 | Cytotoxicity against human A549 cells after 72 hrs by MTT assay | 2013 | European journal of medicinal chemistry, Aug, Volume: 66 | Synthesis, self-aggregation and biological properties of alkylphosphocholine and alkylphosphohomocholine derivatives of cetyltrimethylammonium bromide, cetylpyridinium bromide, benzalkonium bromide (C16) and benzethonium chloride. |
| AID1172735 | Antibacterial activity against Klebsiella pneumoniae D 11750/08 after 24 hrs by microdilution broth method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID763591 | Selectivity index, ratio of IC50 for HUVEC to IC50 for human MCF7 cells | 2013 | European journal of medicinal chemistry, Aug, Volume: 66 | Synthesis, self-aggregation and biological properties of alkylphosphocholine and alkylphosphohomocholine derivatives of cetyltrimethylammonium bromide, cetylpyridinium bromide, benzalkonium bromide (C16) and benzethonium chloride. |
| AID1172758 | Fungicidal activity against Trichosporon asahii 1188 after 48 hrs by modified standard CSLI M27-A2 method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID763590 | Selectivity index, ratio of IC50 for HUVEC to IC50 for human A549 cells | 2013 | European journal of medicinal chemistry, Aug, Volume: 66 | Synthesis, self-aggregation and biological properties of alkylphosphocholine and alkylphosphohomocholine derivatives of cetyltrimethylammonium bromide, cetylpyridinium bromide, benzalkonium bromide (C16) and benzethonium chloride. |
| AID1172729 | Antibacterial activity against Enterococcus sp. J 14365/08 after 24 hrs by microdilution broth method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172761 | Fungicidal activity against Aspergillus fumigatus 231 after 48 hrs by modified standard CSLI M27-A2 method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172767 | Fungicidal activity against Trichophyton mentagrophytes 445 after 120 hrs by modified standard CSLI M27-A2 method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172720 | Antibacterial activity against Staphylococcus aureus CCM 4516/08 after 24 hrs by microdilution broth method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172728 | Bactericidal activity against Staphylococcus epidermidis H 6966/08 after 48 hrs by microdilution broth method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID1172743 | Bactericidal activity against Pseudomonas aeruginosa CCM 1961 after 120 hrs by microdilution broth method | 2014 | Bioorganic & medicinal chemistry letters, Nov-15, Volume: 24, Issue:22
| 6-Hydroxyquinolinium salts differing in the length of alkyl side-chain: synthesis and antimicrobial activity. |
| AID763587 | Amoebicidal activity against Acanthamoeba lugdunensis clinical isolate AcaVNAK02 assessed as minimum trophocidal concentration after 48 hrs by trypan blue exclusion assay | 2013 | European journal of medicinal chemistry, Aug, Volume: 66 | Synthesis, self-aggregation and biological properties of alkylphosphocholine and alkylphosphohomocholine derivatives of cetyltrimethylammonium bromide, cetylpyridinium bromide, benzalkonium bromide (C16) and benzethonium chloride. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |